COLLABORATION AGREEMENT between MONOGRAM BIOSCIENCES, INC. and PFIZER INC. Dated as of May 5, 2006Collaboration Agreement • August 9th, 2006 • Monogram Biosciences, Inc. • In vitro & in vivo diagnostic substances • New York
THIS COLLABORATION AGREEMENT (the “Agreement”) is entered into as of May 5, 2006 (“Effective Date”) between MONOGRAM BIOSCIENCES, INC., a Delaware corporation with its offices at 345 Oyster Point Boulevard, South San Francisco, California 94080 (“Monogram”), and PFIZER INC., a Delaware corporation with its offices at 235 East 42nd Street, New York, New York 10017 (“Pfizer”). Monogram and Pfizer are referred to herein individually as a “Party” or collectively as the “Parties.”
COLLABORATION SECURITY AGREEMENTCollaboration Security Agreement • August 9th, 2006 • Monogram Biosciences, Inc. • In vitro & in vivo diagnostic substances • New York
This Collaboration Security Agreement (this “Agreement”) is made and entered into as of May 5, 2006 by and between Monogram Biosciences, Inc. (the “Grantor”), and Pfizer Inc. (the “Secured Party”).
